beta

AFMD

Affimed N.V.

Afmd

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells.

Market Cap: 61.4 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.affimed.com

Shares Outstanding: 44.7 Million

Float: 44.7 Million

Dividend: 0.0 (0.0%)

Beta: 3.29047

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 315 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1069 trading days

From: 2015-07-17 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud